-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20

Benzinga·09/23/2026 14:25:04
Lake Street analyst Thomas Flaten initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $20.